SOLIGENIX, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SOLIGENIX, INC. (SNGX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $4.02 million as of 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2012-11-14
- 2012-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.02M.
- 2012-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.62M.
- 2012-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.48M.
- 2011-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.79M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2012-09-30 | $4.02M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $4.62M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $5.48M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $6.79M 10-Q · filed 2012-11-14 |
| 2011-09-30 | $7.50M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $4.43M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $7.36M 10-K · filed 2012-03-27 |
| 2009-12-31 | $8.17M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |